These strategies can be divided into targeting TP53 and protein phosphatase 1D (PPM1D), DNA damage repair, ROS, mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) signal transduction pathways, the cell cycle, cancer stem cells (CSCs), and the epigenome. Here, PPM1D is linked to cancer.